We enjoy many fruitful collaborations with scientists and clinicians throughout the United States and the world. A few or our collaborators are highlighted below with a link to their webpage.
Projects on Kv1.3 channels and Kv1.3 channel blockers
Drs. Shawn Iadonato, Eric Tarcha and Ernesto Muñoz. Dr. Iadonato is executive vice president and chief scientific officer of Kineta, Inc. in Seattle, Washington. Dr. Tarcha is senior director for translational development at Kineta, Inc. Dr. Muñoz is associate director of translational immunology and preclinical development at Kineta, Inc.
Dr. Michael W. Pennington. Dr. Pennington is president and CEO of Peptides International, Inc.in Louisville, Kentucky.
Dr. Raymond S. Norton. Dr. Norton is professor of medicinal chemistry and NHMRC principal research fellow at the Monash Institute of Pharmaceutical Sciences, in Melbourne, Australia.
Projects on KCa1.1 channels in fibroblast-like synoviocytes
Dr. Pércio S. Gulko. Dr. Gulko is professor of medicine and chief of the division of rheumatology of the Icahn School of Medicine at Mount Sinai in New York.
Dr. Frank T Horrigan. Dr. Horrigan is associate professor in molecular physiology and biophysics at Baylor College of Medicine.
Projects on antioxidant nanoparticles in autoimmune diseases
Dr. James M. Tour. Dr. Tour is T.T. and W.F. Chao professor of chemistry, professor of computer science, and professor of materials science and nanoengineering at Rice University, in Houston, Texas.
Dr. Robia G. Pautler. Dr. Pautler is associate professor in molecular physiology and biophysics at Baylor College of Medicine.